Eurotrials has signed a sales and marketing contract with US business development company Pharma Services Network.
Pharma Services Network will promote Eurotrials’ “considerable” clinical research capabilities in the North American pharmaceutical and biotechnology markets.
“Our team of experienced physicians and clinicians has conducted clinical studies for many of the top American pharmaceutical companies,” commented Eurotrials Executive Director Rui Melo. “Now, with a representative office and AmeriStart’s organisational support, we hope to expand and improve our standing in the US marketplace.”
Jim Worrell, CEO of Pharma Services Network, pointed to Eurotrials’ “world-class” experience and access to Brazilian patients in the key therapeutic areas of oncology, central nervous system and cardiovascular diseases.
Being a well-respected and leading player in the Brazilian market, Eurotrials can often “navigate a shorter path through Brazil’s regulatory requirements and start a clinical trial sooner than you might expect”, he added. The CRO has the added benefit of a second operational center in Portugal for multicentre trials needing European data.
“Eurotrials is a one-stop shop for Latin America and Southern Europe,” Worrell said.
Contact
Beth Durrance
13000-F South Tryon St., Ste. 166
Charlotte, NC 28278
+ (1) 803.746.4098
beth.durrance@eurotrials.com